Search results
Results from the WOW.Com Content Network
Cannabis use disorder (CUD), also known as cannabis addiction or marijuana addiction, is a psychiatric disorder defined in the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders and ICD-10 as the continued use of cannabis despite clinically significant impairment. [2] [3]
Weekly cannabis use is generally required for the syndrome to occur; synthetic cannabinoids can also cause CHS. [ 6 ] [ 5 ] The underlying mechanism is unclear, with several possibilities proposed. [ 2 ] [ 5 ] Diagnosis is based on the symptoms, as well as the history of cannabis use (including a urine screen test if necessary). [ 6 ]
Over time, the marijuana gateway hypothesis has been studied more and more. In one published study, the use of marijuana was shown not a reliable gateway cause of illicit drug use. [67] However, social factors and environment influence drug use and abuse, making the gateway effects of cannabis different for those in differing social circumstances.
For some, marijuana can also be a great way to relieve some tension and potentially some stress acne. Stress and anxiety increases a hormone called cortisol that can, over time, spike inflammation ...
The link between cannabis use and psychosis is well-established through research.This association is not in doubt. However, as we all learn in high school science, correlation does not imply ...
A dried cannabis flower. The short-term effects of cannabis are caused by many chemical compounds in the cannabis plant, including 113 [clarification needed] different cannabinoids, such as tetrahydrocannabinol (THC), and 120 terpenes, [1] which allow its drug to have various psychological and physiological effects on the human body.
The psychoactive component of cannabis, tetrahydrocannabinol (THC) is not effective in treating emotion-regulation and anxiety-related symptoms. [20] Conversely, THC has been empirically related to an increase anxiety symptoms through impacts on neurological areas impacting serotonin, noradrenalin, GABA and glutamate.
Compare that to stool transplants for Cassaday’s condition, ulcerative colitis, which Grinspan says leads to an improvement in about 25% of people, with 10% improving after taking a placebo.